PATENT CLAIM ANALYSIS

Application Number: 16024407
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["544", "330000"]

Abstract:
Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R 5 , R 6 , R 8 , R 9 , R 11 , X 1 , and X 2  are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.

Claim (Index 16):
A pharmaceutical composition comprising a compound of  claim 15  and a pharmaceutically acceptable carrier of excipient.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.52778
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15120470', '15518541', '15380836', '15304947', '15737535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7785857946435825
- 35 USC 102 Novelty (BERT): 0.5292255547390127
- Combined Prediction Score: 0.7536497706531254
- Mean Citation Score: 317.320912
- Max Citation Score: 369.75244
- Similarity Product: 296.97978469890586

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test